- Home
- A-Z Publications
- Current Medicinal Chemistry
- Previous Issues
- Volume 32, Issue 4, 2025
Current Medicinal Chemistry - Volume 32, Issue 4, 2025
Volume 32, Issue 4, 2025
-
-
ROS-mediated Therapeutics Combined with Metal-based Porphyrin Nanoparticles and their Applications in Tumor Treatment
Authors: Lingyan Yang, Lei Shi, Yihui Liu, Zhenhua Liu, Zejie Tian, Hui Li, Jiayao Zhang, Jun He and Yunmei LiuHigh concentrations of reactive oxygen species (ROS) can disrupt cell structure and induce apoptosis and necrosis of tumor cells. Photodynamic therapy (PDT) and chemodynamic therapy (CDT) are two cancer treatments mediated by reactive oxygen species. Oxygen molecules (O2) are one of the indispensable factors in PDT and hypoxic tumor sites limit its application. However, another ROS-mediated method, CDT, can gen Read More
-
-
-
A New Dawn for Targeted Cancer Therapy: Small Molecule Covalent Binding Inhibitor Targeting K-Ras (G12C)
Authors: Na Li, Chen-Fu Liu, Wen Zhang and Guo-Wu RaoK-Ras is a frequently mutated oncogene in human malignancies, and the development of inhibitors targeting various oncogenic K-Ras mutant proteins is a major challenge in targeted cancer therapy, especially K-Ras(G12C) is the most common mutant, which occurs in pancreatic ductal adenocarcinoma (PDAC), non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and other highly prevalent malignancies. In recent Read More
-
-
-
LINC00667: A Novel Vital Oncogenic LincRNA
Authors: Yaqi Hu, Yifan Zhang, Shuwen Wang, Rui Wang, Qi Yuan, Leiqi Zhu, Fangqi Xia, Mengzhen Xue, Yaqi Wang, Yuanyang Li and Chengfu YuanLong intergenic noncoding RNAs (lincRNAs) have a variety of properties that differ from those of messenger RNAs (mRNAs) encoding proteins. Long intergenic non-protein coding RNA 667 (LINC00667) is a non-coding transcript located on chromosome 18p11.31. Recently, many studies have found that LINC00667 can enhance the progression of various cancers and play a key part in a lot of diseases, such as tumorigenesis. T Read More
-
-
-
SARS-CoV-2 Main Protease Inhibitors from Natural Product Repository as Therapeutic Candidates for the Treatment of Coronaviridae Infections
Authors: Mohammad Abdalmoety Khanfar and Mohammad Issa SalehBackgroundThe main protease (Mpro) is a crucial enzyme for the life cycle of SARS-CoV-2 and a validated target for the treatment of COVID-19 infection. Natural products have been a proper alternative for treating viral diseases by modulating different steps of the life cycle of many viruses.ObjectiveThis review article is designed to summarize the cumulative information of natural-derived Mpro inhibitors that are vali Read More
-
-
-
The Potential Role of Cardiokines in Heart and Kidney Diseases
More LessAs the engine that maintains blood circulation, the heart is also an endocrine organ that regulates the function of distant target organs by secreting a series of cardiokines. As endocrine factors, cardiokines play an indispensable role in maintaining the homeostasis of the heart and other organs. Here, we summarize some of the cardiokines that have been defined thus far and explore their roles in heart and kidney diseases. Finall Read More
-
-
-
Statins, Allies against Antibiotic Resistance?
Due to the ever-increasing rate of antibacterial resistance, the search for effective antibacterial agents has become imperative. Researchers have investigated the potential antimicrobial properties of various classes of nonantibiotic drugs. Statins are a group of antihyperlipidemic drugs with several cholesterol-independent effects, including anti-inflammatory, immune-modulating, antioxidant, and antibacterial effects. In vitro Read More
-
-
-
Genetic and Epigenetic Determinants of COVID-19 Susceptibility: A Systematic Review
BackgroundThe molecular mechanisms regulating coronavirus pathogenesis are complex, including virus-host interactions associated with replication and innate immune control. However, some genetic and epigenetic conditions associated with comorbidities increase the risk of hospitalization and can prove fatal in infected patients. This systematic review will provide insight into host genetic and epigenetic factor Read More
-
-
-
Anti-NMDA Receptor Encephalitis, Human Papillomavirus, and microRNA
More LessBackgroundAnti-N-methyl-d-aspartate (Anti-NMDA) receptor encephalitis is a rare autoimmune disease, which is caused by antibodies attacking NMDA receptors in the brain. Previous studies revealed that this disorder might be induced by vaccination. Vaccination is the most useful strategy to prevent human or animal infectious diseases. Although vaccines can produce immunity against diseases, at low risk, they may trigger Read More
-
-
-
A Molecular Dynamic Simulation, Structural Analysis, and Ex Vivo Insights into the P-glycoprotein Mediated Interactions of Dietary Polyphenols with Cyclin-dependent Kinase Inhibitors: A Potential Strategy to Counteract Drug Efflux
IntroductionP-glycoprotein, an ATP-dependent efflux transporter, plays a crucial role in eliminating cellular toxins and affects the intracellular concentration and bioavailability of CDK 4/6 inhibitors. Moreover, dietary flavonoids are natural bio-enhancers that can effectively inhibit the efflux function of these transporters. Therefore, this study aimed to assess the impact of dietary polyphenols on the inhibition of P-glycoprotei Read More
-
-
-
N,N'-disubstituted Ureas as Novel Antiplatelet Agents: Synthesis, Pharmacological Evaluation and In Silico Studies
Authors: Priscila de Souza Furtado, Gil Mendes Viana, Alana Agnes Silva Camargo de Oliveira, Vitor Won-Held Rabelo, Ingryd Wenderroschy Cerqueira, Caroline Reis Santiago Paschoal, Thiago da Silva Honório, Alice Simon, Carlos Rangel Rodrigues, Paula Alvarez Abreu, Lucio Mendes Cabral and Plínio Cunha SathlerIntroductionThrombotic disorders are among the leading causes of morbidity and mortality worldwide. Drugs used in the prevention and treatment of atherothrombosis have pharmacokinetic limitations and adverse effects such as hemorrhagic conditions, highlighting the importance of developing more effective antiplatelet agents.MethodsIn this work, we synthesized N,N'-disubstituted ureas 3a-3j and evaluated their ant Read More
-
-
-
Does Gut Microbiome have an Effect on Wilson’s Disease Phenotype?
Authors: Shan Gao, Mei Zhou, Hedong Zhang and Zhenchu TangWilson’s Disease (WD), a genetic metabolic disorder, is characterized by the accumulation of copper in the liver and brain, resulting in a range of clinical symptoms. The clinical manifestations of WD vary widely. The present study introduces the distinctive features of intestinal microbiota in Chinese patients with WD, presenting diverse clinical symptoms. It shows a reduction in the diversity of gut microbiota among patients w Read More
-
Volumes & issues
-
Volume 32 (2025)
-
Volume 31 (2024)
-
Volume 30 (2023)
-
Volume 29 (2022)
-
Volume 28 (2021)
-
Volume 27 (2020)
-
Volume 26 (2019)
-
Volume 25 (2018)
-
Volume 24 (2017)
-
Volume 23 (2016)
-
Volume 22 (2015)
-
Volume 21 (2014)
-
Volume 20 (2013)
-
Volume 19 (2012)
-
Volume 18 (2011)
-
Volume 17 (2010)
-
Volume 16 (2009)
-
Volume 15 (2008)
-
Volume 14 (2007)
-
Volume 13 (2006)
-
Volume 12 (2005)
-
Volume 11 (2004)
-
Volume 10 (2003)
-
Volume 9 (2002)
-
Volume 8 (2001)
-
Volume 7 (2000)
Most Read This Month
Article
content/journals/cmc
Journal
10
5
false
en
